Castle Biosciences (NASDAQ:CSTL) Shares Gap Up on Analyst Upgrade
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price gapped up prior to trading on Friday after Robert W. Baird raised their price target on the stock from $36.00 to $37.00. The stock had previously closed at $25.28, but opened at $26.00. Robert W. Baird currently has an outperform rating on the stock. Castle […]
